AU2022268916A1 - Etelcalcetide formulations - Google Patents

Etelcalcetide formulations Download PDF

Info

Publication number
AU2022268916A1
AU2022268916A1 AU2022268916A AU2022268916A AU2022268916A1 AU 2022268916 A1 AU2022268916 A1 AU 2022268916A1 AU 2022268916 A AU2022268916 A AU 2022268916A AU 2022268916 A AU2022268916 A AU 2022268916A AU 2022268916 A1 AU2022268916 A1 AU 2022268916A1
Authority
AU
Australia
Prior art keywords
formulation
etelcalcetide
polysorbate
surfactant
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022268916A
Other languages
English (en)
Inventor
David Lai
Iman Mirzaee Kakhki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of AU2022268916A1 publication Critical patent/AU2022268916A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AU2022268916A 2021-05-06 2022-05-03 Etelcalcetide formulations Pending AU2022268916A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163184924P 2021-05-06 2021-05-06
US63/184,924 2021-05-06
PCT/US2022/027451 WO2022235654A1 (en) 2021-05-06 2022-05-03 Etelcalcetide formulations

Publications (1)

Publication Number Publication Date
AU2022268916A1 true AU2022268916A1 (en) 2023-11-09

Family

ID=81750502

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2022268916A Pending AU2022268916A1 (en) 2021-05-06 2022-05-03 Etelcalcetide formulations

Country Status (7)

Country Link
US (1) US20240207354A1 (https=)
EP (1) EP4333805A1 (https=)
JP (1) JP2024517801A (https=)
AU (1) AU2022268916A1 (https=)
CA (1) CA3218559A1 (https=)
MX (1) MX2023013066A (https=)
WO (1) WO2022235654A1 (https=)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4475196A (en) 1981-03-06 1984-10-02 Zor Clair G Instrument for locating faults in aircraft passenger reading light and attendant call control system
US4447233A (en) 1981-04-10 1984-05-08 Parker-Hannifin Corporation Medication infusion pump
US4439196A (en) 1982-03-18 1984-03-27 Merck & Co., Inc. Osmotic drug delivery system
US4447224A (en) 1982-09-20 1984-05-08 Infusaid Corporation Variable flow implantable infusion apparatus
US4487603A (en) 1982-11-26 1984-12-11 Cordis Corporation Implantable microinfusion pump system
US4486194A (en) 1983-06-08 1984-12-04 James Ferrara Therapeutic device for administering medicaments through the skin
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
MX2012000100A (es) * 2009-07-01 2012-04-02 Fresenius Med Care Hldg Inc Dispositivos de suministro de farmaco y sistemas y metodos relacionados.
MA38724B1 (fr) 2013-06-28 2017-11-30 Amgen Inc Formulation liquide stable d'amg 416 (velcalcétide)
WO2021080822A1 (en) * 2019-10-24 2021-04-29 Amgen Inc. Systems and methods for drug delivery

Also Published As

Publication number Publication date
WO2022235654A1 (en) 2022-11-10
US20240207354A1 (en) 2024-06-27
MX2023013066A (es) 2023-11-15
CA3218559A1 (en) 2022-11-10
EP4333805A1 (en) 2024-03-13
JP2024517801A (ja) 2024-04-23

Similar Documents

Publication Publication Date Title
US20230124105A1 (en) Pharmaceutical composition
CN1809376B (zh) 装在药物容器中的稳定的液体蛋白质制剂
TWI635874B (zh) 艾妥鈣塞(etelcalcetide)(amg 416)之穩定液體調配物
KR20130071434A (ko) 제약 조성물 및 그의 제조 방법
EA036212B1 (ru) Водная композиция, содержащая парацетамол и ибупрофен, и способ ее получения
US20240099965A1 (en) Oxytocin ready to infuse dosage form
US20190388498A1 (en) Ready-to-use oxytocin formulation and uses thereof
AU2022268916A1 (en) Etelcalcetide formulations
US11707509B2 (en) Insulin premix formulation and product, methods of preparing same, and methods of using same
CN103656616B (zh) 巴替非班注射剂及其制备
WO2025235701A1 (en) Ready-to-infuse oxytocin compositions
HK40064553A (en) Pharmaceutical composition
HK40110268A (en) Pharmaceutical composition comprising carbetocin
HK40110268B (en) Pharmaceutical composition comprising carbetocin
HK1244442A1 (en) Pharmaceutical composition
HK1246170B (en) Pharmaceutical composition
HK1244442B (en) Pharmaceutical composition of carbetocin
AU2013204097A1 (en) Pharmaceutical composition